YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
about
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm.Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cellsVerteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancerInhibition of YAP suppresses CML cell proliferation and enhances efficacy of imatinib in vitro and in vivo.Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine.Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell.YAP promotes erlotinib resistance in human non-small cell lung cancer cells.Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.Emerging role of Hippo signalling pathway in bladder cancer.Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell LinesYAP/TAZ at the Roots of Cancer.Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.Dual roles of yes-associated protein (YAP) in colorectal cancer.YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.The Role of Hippo Pathway in Cancer Stem Cell Biology.Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.YAP regulates ALDH1A1 expression and stem cell property of bladder cancer cellsA drug screening assay on cancer cells chronically adapted to acidosisMechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
P2860
Q35819280-F6AE35E8-E980-4855-AA3E-AC9A30122D58Q36595036-988DE5EB-95F7-4BAC-B142-8C54A88FF446Q36843790-E0BC4B06-8D34-4616-98B7-722C5CAA421BQ37229782-D52E678A-AADE-40B6-BAEF-68300AC40D53Q37233609-6D04AA6E-4B58-40DB-8638-D0E02CF7FA4EQ37327370-3CB9828D-FBE4-4EDA-A221-C557F37D8561Q37373749-910C731C-E1B2-4A3D-8FC9-88F4D4D6DCC8Q37427970-050F96E0-03B3-490D-B1E1-D3D459AF15C3Q37588390-45915B93-5DDA-4AF2-911F-744987B0B6F8Q37718224-2E6C7636-3CD8-4FB5-B4EB-411C84F535B6Q38637679-D8DCE15D-E77D-44CA-9F89-0666A96FA356Q38647100-EBBE8406-7F6B-4CEB-B403-C6FF9913F319Q38864941-C0E40E80-BED6-4AB9-8389-507112C76713Q39003420-97AD3A95-E82F-47BC-9D83-13EA2045980FQ41260004-88C3A48F-07DD-45A1-A981-4E9692FC7954Q43651454-EBFDF374-A9FC-437F-9C1F-84E0A23A8030Q47153328-527C1F45-341F-4A7D-B18D-247D31D09ED8Q47291991-F8423DF6-0BF7-4C51-9B43-48F3B387DBD9Q47664161-6784B202-276D-4C02-AC22-1B2836A3A74AQ48588772-9930B5A6-1306-49CE-AA4B-1FEF1620067FQ50078696-A1630308-AB4D-4934-8675-F8A95EC3191FQ55278953-FF9007B7-EACA-4C38-978D-B3E7993AEAF2Q57816335-C42B8BA2-8C87-4F2B-9E08-5EEF01B9FD54Q58698474-653A39B4-707F-4F4C-A63E-1C9EC5822934Q58787445-2127A44C-AD1B-4C96-9776-55B8886EB748
P2860
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@ast
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@en
type
label
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@ast
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@en
prefLabel
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@ast
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@en
P2093
P2860
P356
P1433
P1476
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.
@en
P2093
E Ciamporcero
G Azabdaftari
P2860
P2888
P304
P356
10.1038/ONC.2015.219
P407
P577
2015-06-29T00:00:00Z